Skip to main content
. 2023 Mar 15;14:1141712. doi: 10.3389/fimmu.2023.1141712

Figure 6.

Figure 6

Proposed mechanism of β2AR signaling mediated re-engineering of CD40-CD40L signaling in DCs. An increase in intracellular pIkBα (pIkBα) level with αCD40 treatment is reversed by β2AR signaling, thereby resulting in an altered cytokine production and immuno-retardation of anti-tumor response. Adapted from “NF-KB Signaling Pathway”, by BioRender.com (2022). Retrieved from https://app.biorender.com/biorender-templates.